Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

NCT05619926 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia

Interventions

DRUG: STSP-0601 for Injection

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Collaborators

[object Object]